Talkspace ROA 2020-2025 | TALK
Current and historical return on assets (ROA) values for Talkspace (TALK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Talkspace ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $0.00B | $0.13B | 1.47% |
| 2025-03-31 | $0.00B | $0.13B | 2.20% |
| 2024-12-31 | $0.00B | $0.14B | 1.46% |
| 2024-09-30 | $0.00B | $0.14B | 0.00% |
| 2024-06-30 | $-0.01B | $0.13B | -4.33% |
| 2024-03-31 | $-0.01B | $0.14B | -7.84% |
| 2023-12-31 | $-0.02B | $0.14B | -13.38% |
| 2023-09-30 | $-0.04B | $0.14B | -24.74% |
| 2023-06-30 | $-0.05B | $0.14B | -32.36% |
| 2023-03-31 | $-0.07B | $0.15B | -40.96% |
| 2022-12-31 | $-0.08B | $0.16B | -43.65% |
| 2022-09-30 | $-0.08B | $0.18B | -41.41% |
| 2022-06-30 | $-0.06B | $0.19B | -28.67% |
| 2022-03-31 | $-0.07B | $0.21B | -29.11% |
| 2021-12-31 | $-0.06B | $0.22B | -21.42% |
| 2021-09-30 | $-0.06B | $0.25B | -24.82% |
| 2021-06-30 | $-0.07B | $0.27B | -22.93% |
| 2021-03-31 | $-0.04B | $0.42B | -11.25% |
| 2020-12-31 | $-0.02B | $0.03B | -10.64% |
| 2020-06-30 | $0.00B | $0.42B | -0.96% |
| 2020-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.456B | $0.188B |
| Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Tempus AI (TEM) | United States | $13.327B | 0.00 |
| Doximity (DOCS) | United States | $12.012B | 53.44 |
| Hims & Hers Health (HIMS) | United States | $9.936B | 81.41 |
| IRhythm Technologies (IRTC) | United States | $5.355B | 0.00 |
| Hinge Health (HNGE) | United States | $4.369B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.710B | 39.83 |
| Privia Health (PRVA) | United States | $2.618B | 193.91 |
| Heartflow (HTFL) | $2.348B | 0.00 | |
| Phreesia (PHR) | United States | $1.711B | 0.00 |
| Enovis (ENOV) | United States | $1.686B | 8.91 |
| 10x Genomics (TXG) | United States | $1.631B | 0.00 |
| Omnicell (OMCL) | United States | $1.465B | 28.22 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Azenta (AZTA) | United States | $1.368B | 59.68 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Claritev (CTEV) | United States | $1.131B | 0.00 |
| Evolent Health (EVH) | United States | $1.030B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.655B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
| Carlsmed (CARL) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.296B | 51.87 |
| Outset Medical (OM) | United States | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.232B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.216B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.145B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.121B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.037B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| PROFUSA (PFSA) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |